N. M. Bleehen - Concepedia

Author

N. M. Bleehen

Also Known As

A Bolton, B Hope-Stone, N BLEEHEN, N Bleehen, N M Bleehen, N. Bleehen, N. M. BLEEHEN, N. M. Bleehen, N.M Bleehen, N.M. Bleehen

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Addenbrooke's Hospital Medical Research Council MRC Cancer Unit Middlesex Hospital Queen Elizabeth’s Academy

About

N. M. Bleehen is an author at Addenbrooke's Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.7K
2	Health Sciences	12	13	751
3	Engineering	5	5	116
4	Biomedical Engineering	3	3	94
5	Cell Biology	3	3	140

N. M. Bleehen

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. N. M. Bleehen, E.S. Newlands, Siow Ming Lee, Journal of Clinical Oncology	1995	282
p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus V. Sundaresan, Peter Ganly, P S Hasleton, Lung Cancer Preinvasive LesionsMedicinePathologyBronchial NeoplasmChromosome 3	1993	259
The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease RJ Stephens, DJ Girling, N. M. Bleehen, British Journal of Cancer M0 DiseaseNon-small-cell Lung CancerRadiation TherapyMedicineBronchial Neoplasm	1996	189
The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography S. Falk, R. Ward, N. M. Bleehen British Journal of Cancer Tumour Tissue OxygenationMedicineComputerised P02 HistographyHypoxia (Medicine)Pulmonary Physiology	1992	130
A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. N. M. Bleehen, D.J. Girling, David Machin, British Journal of Cancer Radiation MedicineOncologyRadiation TherapyCancer ManagementPoor Performance Status	1992	112
Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer Fergus Macbeth, T. E. Wheldon, D.J. Girling, Clinical Oncology Radiation MedicineRadiation TherapyRadiation MyelopathyMedicineRandomized Trials	1996	107
Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party N. M. Bleehen, Peter Fayers, D.J. Girling, British Journal of Cancer Twelve Versus SixMedicineMetronomic TherapyClinical TrialsBronchial Neoplasm	1989	89
European School of Oncology Advisory report to the European Commission for the “Europe Against Cancer Programme” European Code Against Cancer Peter Boyle, Umberto Veronesi, M Tubiana, European Journal of Cancer Oncology Advisory ReportEuropean CommissionCancer EpidemiologyMedicineCancer Management	1995	86
Radiation Oncology—Rationale, Technique, Results N. M. Bleehen British Journal of Cancer Radiation MedicineRadiation TherapyMedicineRadiation Therapy PlanningRadiation Oncology—rationale	1980	76
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells Sylvie Souès, Tanya Gottlieb, JV Watson, British Journal of Cancer Tumor BiologyCell RegulationArrest-dependent ModulationMedicineDna Topoisomerase Ii	1994	72

Page 1